BSX vs RENX · P/E 20, rev $10.65B vs rev $8.2M
Boston Scientific Corp (BSX) versus RenX Enterprises Corp. (RENX) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
RenX Enterprises Corp. (RENX) is a real estate - development company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported RENX revenue for 2025-12-31 was $8.2M. Net income was -$16.0M. Revenue was up 3860.7% from 2024-12-31 to 2025-12-31. RENX currently screens at market cap $4.6M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. RENX currently screens at market cap $4.6M.
Not investment advice. Open the BSX and RENX stock pages for the full models.
Not investment advice.